‌

Immunext, Inc. SBIR Phase I Award, February 2017

A SBIR Phase I contract was awarded to ImmuNext in February, 2017 for $299,938.0 USD from the U.S. Department of Health & Human Services.

Is a

SBIR/STTR Award Recipient

Government Agency

Award Type

SBIR0

Contract Number (US Government)

4R44AI129182-020

Award Phase

Phase I0

Award Amount (USD)

299,9380

Date Awarded

February 10, 2017

End Date

July 31, 2017

No article content yet.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like Immunext, Inc. SBIR Phase I Award, February 2017

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.